Company / Profit Margin
RELMADA THERAPEUTICS, INC. Profit Margin History
FY2013-FY2013 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-151.8%
FY2013
5-year range
-151.8% / -151.8%
FY2013-FY2013
Trend
-
vs FY2012
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-151.8% in FY2013.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2013 | -151.8% | - |
As of FY2013 · SEC 10-K · Updated Jun 28, 2026